In this study, we report that MMRi62 has advantages over conventional MDM2 inhibitors in cell death induction in melanoma cells and SC-62-1 as MMRi62 derivatives has improved activity and is useful in eliminating melanoma cells with acquired resistance. Here, MDM2 is linked to melanoma.